CHEONGJU, South Korea--(BUSINESS WIRE)--Celltrion Pharm (KOSDAQ: 068706), a South Korean biopharmaceutical firm, said on September 16 that it has inked a strategic trilateral agreement with a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback